Detalles de la búsqueda
1.
Considerations in Gender-Affirming Hormone Therapy in Transgender and Gender Diverse Patients Undergoing Liver Transplantation.
Am J Transplant;
2024 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38729612
2.
Forecasting the Incidence and Prevalence of Inflammatory Bowel Disease: A Canadian Nationwide Analysis.
Am J Gastroenterol;
2024 Mar 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38299598
3.
Hormonal Contraceptives Reduce Active Symptomatic Disease but May Increase Intestinal Inflammation in IBD.
J Clin Gastroenterol;
58(3): 271-276, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38349017
4.
AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review.
Gastroenterology;
162(4): 1334-1342, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35183361
5.
Perianal Fistulas Are Associated with Persistently Higher Direct Health Care Costs in Crohn's Disease: A Population-Based Study.
Dig Dis Sci;
68(12): 4350-4359, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37796405
6.
Earlier Anti-TNF Initiation Leads to Long-term Lower Health Care Utilization in Crohn's Disease but Not in Ulcerative Colitis.
Clin Gastroenterol Hepatol;
20(11): 2607-2618.e14, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35247552
7.
Hospitalization With Clostridioides difficile in Pediatric Inflammatory Bowel Disease: a Population-Based Study.
J Pediatr Gastroenterol Nutr;
75(2): 173-180, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35675701
8.
Ranking microbiome variance in inflammatory bowel disease: a large longitudinal intercontinental study.
Gut;
70(3): 499-510, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32536605
9.
Anxiety and Depression Leads to Anti-Tumor Necrosis Factor Discontinuation in Inflammatory Bowel Disease.
Clin Gastroenterol Hepatol;
19(6): 1200-1208.e1, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32668341
10.
Trends in Corticosteroid Use During the Era of Biologic Therapy: A Population-Based Analysis.
Am J Gastroenterol;
116(6): 1284-1293, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33767103
11.
Dose Augmentation of Tumor Necrosis Factor Inhibitors is Frequently Performed in Persons With Inflammatory Bowel Disease in the Absence of Objective Evidence of Active Inflammation.
J Clin Gastroenterol;
55(7): 602-608, 2021 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32694264
12.
Events Within the First Year of Life, but Not the Neonatal Period, Affect Risk for Later Development of Inflammatory Bowel Diseases.
Gastroenterology;
156(8): 2190-2197.e10, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30772341
13.
Approaching Digestive Health Care in Transgender and Gender-Diverse Communities.
Gastroenterology;
166(3): 369-375.e2, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38395524
14.
Past and Future Burden of Inflammatory Bowel Diseases Based on Modeling of Population-Based Data.
Gastroenterology;
156(5): 1345-1353.e4, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30639677
15.
Effectiveness of Dose De-escalation of Biologic Therapy in Inflammatory Bowel Disease: A Systematic Review.
Am J Gastroenterol;
115(11): 1768-1774, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33156094
16.
Longitudinal Trends in the Direct Costs and Health Care Utilization Ascribable to Inflammatory Bowel Disease in the Biologic Era: Results From a Canadian Population-Based Analysis.
Am J Gastroenterol;
115(1): 128-137, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31895723
17.
Inflammatory bowel disease and new-onset psychiatric disorders in pregnancy and post partum: a population-based cohort study.
Gut;
68(9): 1597-1605, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30630948
18.
Approaching Digestive Health Care in Transgender and Gender-Diverse Communities.
Clin Gastroenterol Hepatol;
22(3): 441-447.e2, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38395527
19.
Research Considerations in Digestive and Liver Disease in Transgender and Gender-Diverse Populations.
Gastroenterology;
165(3): 523-528.e1, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37599011
20.
Upfront Combination Therapy, Compared With Monotherapy, for Patients Not Previously Treated With a Biologic Agent Associates With Reduced Risk of Inflammatory Bowel Disease-related Complications in a Population-based Cohort Study.
Clin Gastroenterol Hepatol;
17(9): 1788-1798.e2, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30448599